跳至主要内容
临床试验/NCT06591806
NCT06591806进行中(未招募)不适用

A Multicenter, Prospective, Longitudinal, Observational Study in Children and Adults With Stargardt Disease Related Atrophy Secondary to Biallelic Mutations in the ABCA4 Gene

AAVantgarde Bio Srl4 个研究点 分布在 2 个国家目标入组 80 人开始时间: 2024年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
80
试验地点
4
主要终点
To measure the change from baseline in Fundus Autofluorescence

研究概览

简要总结

This multicenter, prospective, longitudinal, observational study in approximately 80 subjects with Stargardt disease secondary to biallelic mutations in the ABCA4 gene (STGD1) aims to evaluate prognostic factors of disease progression, and to further characterize the patient population for future clinical studies.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
8 Years 至 50 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female subjects between 8 and 50 years of age at the time of enrolment.
  • Willingness to adhere to the protocol as evidenced by written informed consent if the subject is 18 years or older. If the subject is under 18 years of age, written assent must be obtained from the subject and written informed consent must be obtained from the subject's legally authorized representative (parent or legal guardian).
  • Confirmed mutation in the ABCA4 gene.

排除标准

  • History of uveitis.
  • Any ocular disease in either eye that may confound assessment of the retina morphologically and functionally.
  • Any pathology of the posterior segment other than ABCA4 retinopathy.
  • Presence of any other genetic mutation(s) that have been associated with retinal or macular dystrophy.

结局指标

主要结局

To measure the change from baseline in Fundus Autofluorescence

时间窗: 24 months

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验